⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL723439 | 0.79 | — | — | |
| SCHEMBL5056758 | 0.79 | RAB9A (0.62) | — | |
| SCHEMBL565974 | 0.79 | CES2 (0.64) | — | |
| SCHEMBL13656482 | 0.79 | CES2 (0.56) | — | |
| SCHEMBL9731472 | 0.78 | NPC1 (0.50) | — | |
| SCHEMBL9731474 | 0.78 | NPC1 (0.50) | — | |
| SCHEMBL4196929 | 0.77 | CES2 (0.61) | — | |
| SCHEMBL14082103 | 0.77 | — | — | |
| SCHEMBL31560056 | 0.77 | CES2 (0.54) | — | |
| SCHEMBL5873384 | 0.77 | CES2 (0.61) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 353 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109851507-B | Application of scandium-containing rare earth catalyst in catalysis of para-alkylation reaction of aromatic amine | 苏州大学 | 2022-02-01 | — | — | CN | claimed |
| US-20200388881-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL THIOPHENE COMPOUNDS OR DERIVATIVES OF THIOPHENE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| CN-109851507-A | Application of the rare earth catalyst containing scandium in catalysis aromatic amine contraposition alkylated reaction | 苏州大学 | 2019-06-07 | — | — | CN | claimed |
| US-20100099880-A1 | Alternate Process for Remifentanil Preparation | MALLINCKRODT INC. | 2010-04-22 | — | — | US | claimed |
| EP-2125730-A2 | NEW PROCESS FOR REMIFENTANIL SYNTHESIS | Mallinckrodt Inc. (US) | 2009-12-02 | — | — | EP | claimed |
| EP-2081899-A2 | ALTERNATE PROCESS FOR REMIFENTANIL PREPARATION | Mallinckrodt Inc. (US) | 2009-07-29 | — | — | EP | claimed |
| WO-2008066708-A2 | NEW PROCESS FOR REMIFENTANIL SYNTHESIS | MALLINCKRODT INC. (US) | 2008-06-05 | — | — | WO | claimed |
| WO-2008045192-A2 | ALTERNATE PROCESS FOR REMIFENTANIL PREPARATION | MALLINCKRODT INC. (US) | 2008-04-17 | — | — | WO | claimed |
| EP-0647225-A1 | 3-ARYLURACIL DERIVATIVES AND THEIR USE AS HERBICIDES | Novartis AG (CH) | 1995-04-12 | — | — | EP | claimed |
| US-12018015-B2 | Methods and compositions for targeting PD-L1 | ALIGOS THERAPEUTICS, INC. (US) | 2024-06-25 | — | — | US | disclosed |
| US-20240199647-A1 | ANTI-VIRAL COMPOUNDS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2024-06-20 | — | — | US | disclosed |
| US-20240182444-A1 | ANTI-VIRAL COMPOUNDS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2024-06-06 | — | — | US | disclosed |
| EP-4366831-A1 | ANTI-VIRAL COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2024-05-15 | — | — | EP | disclosed |
| WO-2024097296-A1 | ANTI-VIRAL COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |
| EP-0187390-A2 | Novel allylic amines | MERRELL DOW PHARMACEUTICALS INC. (US) | 1986-07-16 | — | — | EP | disclosed |
| US-4522998-A | VINYL ESTER, ALPHA-OLEFIN, AND VINYLCYCLOPROPANEDICARBOXYLATE POLYESTER | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1985-06-11 | — | — | US | disclosed |
| US-4522999-A | WITH UNSATURATED ESTER | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1985-06-11 | — | — | US | disclosed |
| US-4409355-A | EMULSION POLYMERIZATION | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1983-10-11 | — | — | US | disclosed |
| US-4130523-A | High solids latexes | UNION CARBIDE CORPORATION (US) | 1978-12-19 | — | — | US | disclosed |
| US-4039500-A | EMULSION POLYMERIZATION, CROSSLINKING | UNION CARBIDE CORPORATION (US) | 1977-08-02 | — | — | US | disclosed |